Tramadol controlled release - Toray

Drug Profile

Tramadol controlled release - Toray

Alternative Names: THCR; Tramadol hydrochloride controlled-release; Tramadol hydrochloride slow-release; Tramadol hydrochloride SR; TRK-091

Latest Information Update: 21 Jul 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Purdue Pharma
  • Developer Toray
  • Class Antidepressants; Cyclohexanols; Dimethylamines; Erectile dysfunction therapies; Opioid analgesics; Phenyl ethers; Small molecules
  • Mechanism of Action Opioid receptor agonists; Serotonin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 08 Mar 2016 Biomarkers information updated
  • 21 Jul 2010 Discontinued - Phase-II for Pain in Japan (PO)
  • 02 Apr 2004 A case report has been added to the drug interactions and adverse events sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top